These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24114861)

  • 21. The issue of multiplicity in noninferiority studies.
    Ke C; Ding B; Jiang Q; Snapinn SM
    Clin Trials; 2012 Dec; 9(6):730-5. PubMed ID: 22879575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sample size estimation in single-arm clinical trials with multiple testing under frequentist and Bayesian approaches.
    Zaslavsky BG; Scott J
    J Biopharm Stat; 2012; 22(4):819-35. PubMed ID: 22651117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calculation of tolerance limits and sample size determination for clinical trials with dichotomous outcomes.
    Zaslavsky BG
    J Biopharm Stat; 2007; 17(3):481-91. PubMed ID: 17479395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resampling in multiple-dose factorial designs.
    Frommolt P; Hellmich M
    Biom J; 2009 Dec; 51(6):915-31. PubMed ID: 20029896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. General theory of mixture procedures for gatekeeping.
    Dmitrienko A; Tamhane AC
    Biom J; 2013 May; 55(3):402-19. PubMed ID: 23423821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing the order of hypotheses in serial testing of multiple endpoints in clinical trials.
    Zhang Z; Wang C; Troendle JF
    Stat Med; 2015 Apr; 34(9):1467-82. PubMed ID: 25620627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testing bioequivalence for multiple formulations with power and sample size calculations.
    Zheng C; Wang J; Zhao L
    Pharm Stat; 2012; 11(4):334-41. PubMed ID: 22692852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of multiplicity adjustment strategies for correlated binary endpoints.
    Leon AC; Heo M
    J Biopharm Stat; 2005; 15(5):839-55. PubMed ID: 16080237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiplicity adjustment for multiple endpoints in clinical trials with multiple doses of an active treatment.
    Quan H; Luo X; Capizzi T
    Stat Med; 2005 Jul; 24(14):2151-70. PubMed ID: 15909290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Multiplicity of inferences in clinical trials: adjustment methods, clinical interpretation issues].
    Jouan-Flahault C; Casset-Semanaz F; Minini P
    Med Sci (Paris); 2004 Feb; 20(2):231-5. PubMed ID: 14997445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges to multiple testing in clinical trials.
    James Hung HM; Wang SJ
    Biom J; 2010 Dec; 52(6):747-56. PubMed ID: 20589856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging standards in statistical practice: implications for clinical trials in rehabilitation medicine.
    Millis SR
    Am J Phys Med Rehabil; 2003 Oct; 82(10 Suppl):S32-7. PubMed ID: 14502037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some comments on frequently used multiple endpoint adjustment methods in clinical trials.
    Sankoh AJ; Huque MF; Dubey SD
    Stat Med; 1997 Nov; 16(22):2529-42. PubMed ID: 9403954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An overview of statistical planning to address subgroups in confirmatory clinical trials.
    Koch GG; Schwartz TA
    J Biopharm Stat; 2014; 24(1):72-93. PubMed ID: 24392979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A graphical approach to sequentially rejective multiple test procedures.
    Bretz F; Maurer W; Brannath W; Posch M
    Stat Med; 2009 Feb; 28(4):586-604. PubMed ID: 19051220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiplicity adjustment big and small in clinical studies.
    Hsu JC
    Clin Pharmacol Ther; 2010 Aug; 88(2):251-4. PubMed ID: 20592727
    [No Abstract]   [Full Text] [Related]  

  • 37. Selection of hypothesis weights and ordering when testing multiple hypotheses in clinical trials.
    Wiens BL; Dmitrienko A; Marchenko O
    J Biopharm Stat; 2013; 23(6):1403-19. PubMed ID: 24138439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statistical methods for evaluating multiple sclerosis therapies.
    Petkau J
    Semin Neurol; 1998; 18(3):351-75. PubMed ID: 9817539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adaptive design in clinical research: issues, opportunities, and recommendations.
    Chang M; Chow SC; Pong A
    J Biopharm Stat; 2006 May; 16(3):299-309; discussion 311-2. PubMed ID: 16724486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Step-up testing procedure for multiple comparisons with a control for a latent variable model with ordered categorical responses.
    Lin Y; Kwong KS; Cheung SH; Poon WY
    Stat Med; 2014 Sep; 33(21):3629-38. PubMed ID: 24757077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.